Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
#pharmaceuticals #patents #drugdevelopment #biotech #smallmolecule #patentlaw #pharmapatents #drugpatents #innovation #intellectualproperty To view or add a comment, sign in Lipitor made $125 billion before patent expiry
However, as with any treatment, it is important to consider both the benefits and the risks
The complaint alleges that Novo Nordisk was negligent in allowing Ozempic to be sold, failed to warn, negligently designed Ozempic and other semaglutide drugs, negligently marketed the drug, and violated Pennsylvania unfair trade practices
Furthermore, this medication has shown positive effects on metabolic health, including improved blood sugar regulation and a 20% reduction in the risk of serious cardiovascular events or mortality in adults without diabetes
US$ 22.15
US$ 27.60
US$ 22.64
US$ 20.30
US$ 24.41
US$ 25.55
US$ 22.86
